Skip to content
Boston, MA

Growth inside regulated categories

Healthcare, biotech, and education dominate here — and all three carry constraints that make standard marketing tracking a genuine compliance risk.

Healthcare SystemsBiotech & PharmaMedical DevicesHigher EducationEnterprise SaaS

Benchmarks in this market

Avg. contract value
+61%Avg. contract value
Organic traffic
+312%Organic traffic
Win rate
+44%Win rate
Sales cycle length
-38%Sales cycle length

How we work here: Remotely from our San Francisco office, with ET coverage for calls and travel for kickoffs. We don't claim a Boston office we don't have.

Clients across every market

NorthwindLumen LabsHarborlineVerdantAtlas FoodsPoka HealthBrightsideCobalt BankMeridianArdentFoundryKestrel
Market profile

What's actually different about greater Boston

Boston concentrates healthcare systems, biotech, medical devices, higher education, and enterprise software into one metro. What unites them is regulation: HIPAA, FDA promotional guidance, IRB processes, and student privacy rules all shape what you can measure and claim. Most marketing stacks we audit here are quietly non-compliant, usually because a standard analytics pixel is transmitting data it shouldn't.

Standard tracking is a live compliance risk

Sending PHI to ad platforms through a conventional pixel is a genuine HIPAA exposure, and most healthcare sites are doing it without knowing. Privacy-safe measurement architecture is the first thing we build in this market, before any campaign work.

YMYL content faces an elevated bar

Health and financial content is held to higher E-E-A-T standards. Content without demonstrable clinical or expert authorship struggles to rank at all here, regardless of technical optimization.

Institutional buying is slow by design

Hospital systems, universities, and pharma have committee structures and procurement processes that cannot be compressed. Marketing programs need to be scoped for 12–24 month horizons or they get abandoned before they mature.

Academic credibility carries real weight

Peer-reviewed citations, clinical review, and institutional partnerships influence buying here more than in any other market we work in. Content strategy should be built around earning those signals rather than around volume.

In their words

The part clients actually remember.

Not the reports. The uncomfortable conversation that changed the trajectory.

We were terrified of going light-mode in a category where everything is dark. It turned out to be the whole point — people finally remembered who we were.
Jonah VestergaardCo-founder, Lumen Labs
Our offices had been competing against each other in Google for years without anyone realizing it. Fixing that alone changed the numbers before any new content was even published.
Corinne DelacroixManaging Partner, Ardent Legal
We were generating 400 leads a month and closing nothing. Now we generate almost no leads and close eight-figure pipeline. Marketing and sales finally look at the same screen.
Bernard Osei-TutuVP Marketing, Foundry Systems
Local questions

Boston questions, answered straight.

We sign BAAs and design privacy-safe tracking architecture that keeps PHI out of ad platforms, and we document it for your compliance team. We're not a covered entity ourselves — our role is building systems that keep you compliant and being able to prove how.

Boston, MA

Let's look at your numbers.

A free 30-minute teardown of your funnel, ads, and site — run against what actually works in greater Boston. You keep the findings either way.